JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today reported results for the year and the quarter ended December 31, 2015.
“2015 was a year of exceptional strategic, operational and financial performance for Teva”, stated Erez Vigodman, President and CEO of Teva.
“Our strong focus on solidifying the foundation of Teva and improving the fundamentals of our business is manifesting itself in the consistent improvement of our operating and financial results.
